SCHEMBL31587008

SCHEMBL31587008

Cc1ccnc(-n2ccc(CC(=O)Nc3cc(C4CC4)n[nH]3)n2)c1

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 12/20 0.38
▸ CCNE1 P24864 11/20 0.38
▸ KDM5A P29375 4/20 0.37
▸ KDM4C Q9H3R0 4/20 0.37
▸ KDM5B Q9UGL1 4/20 0.37
▸ CRACR2A Q9BSW2 1/20 0.35
▸ KDM2B Q8NHM5 1/20 0.35
▸ GSK3B P49841 5/20 0.34
▸ KDM4A O75164 1/20 0.34
▸ CCNA2 P20248 1/20 0.34
▸ CCNA1 P78396 1/20 0.34
▸ GPBAR1 Q8TDU6 1/20 0.34
▸ AR P10275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31587320 0.90 CCNE1 (0.39) CDK2CCNE1KDM5AKDM4CKDM5B
SCHEMBL31587024 0.87 CRACR2A (0.44) CDK2CCNE1KDM5AKDM4CKDM5B
SCHEMBL31587666 0.84 CDK2 (0.40) CDK2CCNE1CRACR2ACCNA2CCNA1
SCHEMBL31587173 0.83 CDK2 (0.53) CDK2CCNE1GSK3BCCNA2CCNA1
SCHEMBL31587181 0.83 CDK2 (0.38) CDK2CCNE1CRACR2AGSK3BCCNA2
SCHEMBL31587731 0.83 CCNE1 (0.39) CDK2CCNE1GSK3B
SCHEMBL31516946 0.83 CDK2 (0.37) CDK2CCNE1GSK3BCCNA2CCNA1
SCHEMBL31587062 0.82 CDK2 (0.37) CDK2CCNE1CRACR2AGSK3BCCNA2
SCHEMBL31587604 0.81 CCNE1 (0.36) CDK2CCNE1CRACR2AGSK3BAR
SCHEMBL31587991 0.80 CRACR2A (0.38) CDK2CCNE1CRACR2AGSK3BCCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025104236-A1 PYRAZOLE COMPOUNDS AS CULLIN RING UBIQUITIN LIGASE COMPOUNDS PROXYGEN GMBH (AT) 2025-05-22 — — WO claimed
WO-2025104236-A1 PYRAZOLE COMPOUNDS AS CULLIN RING UBIQUITIN LIGASE COMPOUNDS PROXYGEN GMBH (AT) 2025-05-22 — — WO disclosed
Send feedback